Elsevier is a global information analytics company that specializes in scientific, technical, and medical content and services. The company publishes academic journals, books, and digital solutions primarily serving researchers, healthcare professionals, and academic institutions. Elsevier provides research databases, citation tools, and analytical platforms to support scientific discovery and evidence-based decision making.
Reviewers generally appreciate Elsevier's extensive journal portfolio and the high quality of its academic publishing services. Many highlight the platform's comprehensive resources and sophisticated search algorithms, which significantly enhance research capabilities.
The editorial feedback received during the publication process is often described as constructive and beneficial. However, concerns about value for money are prevalent, particularly for smaller research groups that find the pricing structure challenging. Some users note that the submission process can be cumbersome, with outdated systems and long review cycles causing frustration. Additionally, while the platform is reliable, there are occasional issues with customer support responsiveness.
Summary generated with AI from recent reviews
Same method for every company: overall rating, legitimacy checks, the average rating of reviews mentioning each area and the 6-month trend · Publishing Houses.
| Company | Overall | Legit | Trend | Reviews |
|---|---|---|---|---|
 | — | 67 out of 100 | — | 0 |
| 2.2 out of 5 (poor) | 100 out of 100 | +24% | 211 | |
| 4.0 out of 5 (good) | 100 out of 100 | −20% | 100 | |
| 4.9 out of 5 (good) | 100 out of 100 | — | 61 | |
| 2.3 out of 5 (poor) | 100 out of 100 | — | 31 |
12 reviews of Elsevier. Filter by what matters to you.
We've used Elsevier for institutional access for over 5 years. The database is comprehensive and search tools are powerful. Occasional downtime during peak hours but overall very dependable service.
Solid platform with extensive journal coverage. Some journals have very long review cycles which can be frustrating when you're trying to meet deadlines. Content quality is consistently high.
Published two papers through their journals this year. Editorial feedback was constructive and helped improve the final manuscripts significantly. Timeline from submission to publication was about 6 months which is reasonable for the field.
The quality of journals and databases is undeniable - really comprehensive coverage across scientific fields. However, the subscription costs are quite steep for smaller institutions. The content is worth it but pricing could be more accessible.
Quick answers to the questions people ask most.
Elsevier is a global information analytics company that provides scientific, technical, and medical information products and services. We offer academic journals, books, databases, research tools, and analytics solutions to researchers, students, healthcare professionals, and institutions worldwide.
You can access Elsevier content through institutional subscriptions via your university or organization's library, individual subscriptions, or pay-per-view options. Many institutions provide remote access to their students and faculty through VPN or proxy services.
ScienceDirect is Elsevier's leading platform providing access to over 16 million scientific articles from more than 4,000 journals and 40,000 books. You can search, browse, and download content if you have access through your institution or personal subscription.
You can contact Elsevier support through their website's help center, email support, or phone. Support options vary by region and service type, with dedicated teams for researchers, librarians, and healthcare professionals.
Elsevier follows strict peer review standards with policies on ethical publishing, plagiarism detection, and conflict of interest disclosure. Each journal has specific submission guidelines available on the journal's homepage, and the review process typically takes 2-4 months depending on the journal.
Yes, Elsevier offers various open access options including fully open access journals, hybrid journals with open access articles, and repository deposit options. Authors can choose immediate open access publication for an article processing charge or delayed open access after an embargo period.
Subscription costs vary significantly based on the type of access, number of journals, institution size, and geographic location. Individual journal subscriptions can range from hundreds to thousands of dollars annually, while institutional packages are typically negotiated based on specific needs.
Anyone can write a CrowdTrust review. People who write reviews have ownership to edit or delete them at any time, and they'll be displayed as long as an account is active.
Been working with them for journal submissions for 3 years now. Generally smooth process and good communication from editors.
Refund policies vary by product and subscription type, with institutional subscriptions typically requiring advance notice for cancellation. Individual subscribers may be eligible for prorated refunds under certain circumstances, and specific terms are outlined in the subscription agreement.
Yes, Elsevier offers various training resources including webinars, workshops, online tutorials, and research support tools. They provide guidance on manuscript preparation, research methodology, and using their platforms effectively.
You can request permission to reuse Elsevier content through their Rights & Permissions portal or RightsLink service. The process varies depending on the type of use, with some educational and research uses potentially qualifying for free permissions under fair use guidelines.
Elsevier is a global information analytics company that specializes in scientific, technical, and medical content and services. The company publishes academic journals, books, and digital solutions primarily serving researchers, healthcare professionals, and academic institutions. Elsevier provides research databases, citation tools, and analytical platforms to support scientific discovery and evidence-based decision making.
